Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.
Shinkai M, Tsushima K, Tanaka S, Hagiwara E, Tarumoto N, Kawada I, Hirai Y, Fujiwara S, Komase Y, Saraya T, Koh H, Kagiyama N, Shimada M, Kanou D, Antoku S, Uchida Y, Tokue Y, Takamori M, Gon Y, Ie K, Yamazaki Y, Harada K, Miyao N, Naka T, Iwata M, Nakagawa A, Hiyama K, Ogawa Y, Shinoda M, Ota S, Hirouchi T, Terada J, Kawano S, Ogura T, Sakurai T, Matsumoto Y, Kunishima H, Kobayashi O, Iwata S.. Careau V, et al. Curr Biol. 2021 Aug 26:S0960-9822(21)01120-9. doi: 10.1016/j.cub.2021.08.016. Online ahead of print. Curr Biol. 2021. PMID: 34453886. Nature. 2021 Sep;597(7875):285-289. doi: 10.1038/s41586-021-03856-x. Epub 2021 Sep 1. Nature. 2021. PMID: 34471284